1
-
8
of
8
results (0.31 seconds)
Sort By:
-
Give Me Some Credibility: Addressing the Challenge of Volatility in Value-Based Contracts—Part 2
Give Me Some Credibility: Addressing the Challenge of Volatility in Value-Based Contracts—Part 2 Discover the key components of value-based care (VBC) contracts and their impact on provider ...- Authors: Maria Knox, James Pisko, Keith Passwater
- Date: May 2023
- Competency: External Forces & Industry Knowledge; Results-Oriented Solutions; Technical Skills & Analytical Problem Solving
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health care quality; Health & Disability>Health insurance; Predictive Analytics; Health & Disability>Provider networks; Health & Disability>Provider risk; Predictive Analytics>Modeling techniques
-
Prevalence of Supplemental Benefits in the Medicare Advantage Marketplace: 2017 to 2021
Prevalence of Supplemental Benefits in the Medicare Advantage Marketplace: 2017 to 2021 This article focuses on mandatory supplemental benefits offered by general enrollment plans and Dual ...- Authors: Julia Friedman
- Date: Mar 2021
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability>Health care; Social Insurance>Medicare
-
Intimate Partner Violence: The Shadow Pandemic Part 1: Background Briefing
Intimate Partner Violence: The Shadow Pandemic Part 1: Background Briefing In this paper, we shine a light on the global public health epidemic of intimate partner violence (IPV). This first ...- Date: Mar 2021
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability>Health care; Health & Disability>Health care quality; Health & Disability>Health risks
-
Biosimilars, Part 3: Humira Biosimilar Launches
Biosimilars, Part 3: Humira Biosimilar Launches The big event of 2023 is the launch of multiple Humira biosimilars, which began in January with the arrival of Amgen’s Amjevita on the market. The ...- Authors: Tony Pistilli, Greg Warren
- Date: Nov 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance; Public Policy; Public Policy; Public Policy
-
Understanding Health in the Big Picture
Understanding Health in the Big Picture Social determinants of health (SDoH) have been a topic of growing interest in recent years, yet consensus about what the phrase represents and how ...- Authors: Jill Van Den Bos, Stoddard Davenport
- Date: Aug 2021
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability>Health care; Health & Disability>Health care quality; Health & Disability>Health risks
-
Biosimilars, Part 4: The Financial Impact
Biosimilars, Part 4: The Financial Impact Savings from biosimilars have accelerated significantly in the past few years. There has been a number of relatively recent biosimilar launches that can ...- Authors: Greg Warren, Tony Pistilli
- Date: Nov 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance; Public Policy; Public Policy; Public Policy
-
Intimate Partner Violence: The Shadow Pandemic Part 2: Intimate Partner Violence During the COVID-19 Pandemic
Intimate Partner Violence: The Shadow Pandemic Part 2: Intimate Partner Violence During the COVID-19 Pandemic This article on IPV focuses on IPV during the COVID-19 pandemic blockquote { margin: ...- Date: Mar 2021
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability>Health care; Health & Disability>Health care quality; Health & Disability>Health risks
-
Biosimilars, Part 5: Payer Decision Making
Biosimilars, Part 5: Payer Decision Making The coming wave of biosimilars could dramatically affect prescription drug costs and benefit strategies over the next several years. The launch of many ...- Authors: Greg Warren, Tony Pistilli
- Date: Jan 2024
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Chronic health management - Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance